IBC Policies
The Institution Biosafety Committee (IBC) is responsible for the review of University research and teaching activities involving recombinant and synthetic nucleic acid molecules, infectious agents, biologically-derived toxins, or other potentially hazardous biological agents as described in the University of Minnesota Board of Regents Policy.
The IBC’s policies are periodically evaluated and revised as influenced by regulatory agencies and administrative changes.
All approved policy revisions will be posted on this site as they are implemented, along with the revision date for reference. The most current version of all Institutional Biosafety Committee policies are listed here.
General Administration
Organization & Roles of IBC
| Number | Title |
|---|---|
| 200 | Membership |
| 201 | IBC Composition |
| 202 | Conflict of Interest |
| 203 | IBC Chairpersons |
| 204 | Member Responsibilities |
| 205 | Consultants |
| 206 | Biological Safety Officer |
| 207 | Executive Committee |
Functions & Operations
Review of Research/Activities
| Number | Title |
|---|---|
| 400 | Application Review |
| 401 | Continuing Review |
| 402 | Amendments |
| 403 | IBC Actions After Review |
| 404 | Non-Compliance with IBC Oversight |
| 405 | Expiration, Inactivation, Completion |
| 406 | Incident Reporting |
| 407 | Suspension, Termination |
| 408 | Appeals Suspension or Termination |
| 409 | Infectious (Not to Humans) Agents |
Investigator Responsibilities
| Number | Title |
|---|---|
| 700 | PI Responsibilities |
| 701 | Required Training |
| 702 | PI Signature Requirements |
| 703 | Disagreement with Committee Decisions |
| 704 | Certification of Biological Safety Cabinets |